Abstract
A new catalytic system was developed for the direct catalytic asymmetric aldol reaction of thioamides. The new lithium-free Cu catalyst (second-generation catalyst) exhibited enhanced catalytic efficiency over the previously developed catalyst comprising [Cu(CH3CN) 4]PF6/Ph-BPE/LiOAr (first-generation catalyst), which required a tedious catalyst preparation process. In the reaction with the second-generation catalyst, the intermediate Cu-aldolate functioned as a Brønsted base to generate thioamide enolate, efficiently driving the catalytic cycle. The present aldol methodology culminated in a concise asymmetric synthesis of atorvastatin (Lipitor®: atorvastatin calcium), a widely prescribed HMG-CoA reductase inhibitor for lowering low-density lipoprotein cholesterol.
Original language | English |
---|---|
Pages (from-to) | 6539-6546 |
Number of pages | 8 |
Journal | Tetrahedron |
Volume | 67 |
Issue number | 35 |
DOIs | |
Publication status | Published - 2011 Sept 2 |
Externally published | Yes |
Keywords
- Aldol reaction
- Asymmetric catalysis
- Atorvastatin
- Mesitylcopper
- Thioamide
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry